Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of interventions as a possible treatment for
pancreatic tumor.
The interventions involved in this study are:
- FOLFIRINOX which is made up of 4 different drugs:
- 5-Fluorouracil (5-FU)
- Oxaliplatin
- Irinotecan
- Leucovorin
- Losartan
- Nivolumab
- Radiation Therapy
- Surgery
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Bristol-Myers Squibb Lustgarten Foundation Stand Up To Cancer